Seawolf Therapeutics Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 32

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $100M

  • Investors
  • 8

Seawolf Therapeutics General Information

Description

Operator of a gene therapy company based in San Diego, California. The company develops next-generation non-viral genetic medicines, enabling patients living with debilitating unmet medical needs to get suitable therapeutics.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 9880 Campus Point Drive
  • Suite 210
  • San Diego, CA 92121
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 9880 Campus Point Drive
  • Suite 210
  • San Diego, CA 92121
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Seawolf Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC (Series A) 16-Nov-2026 $100M Completed Startup
1. Seed Round Completed Startup
To view Seawolf Therapeutics’s complete valuation and funding history, request access »

Seawolf Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Seawolf Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Seawolf Therapeutics Patents

Seawolf Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026029828-A2 Unsaturated ionizable lipids and nanoparticle compositions thereof Pending 14-May-2024
WO-2026029828-A3 Unsaturated ionizable lipids and nanoparticle compositions thereof Pending 14-May-2024
AU-2025235582-A1 Enhanced nuclear delivery of dna and compositions for use in practicing the same Pending 11-Mar-2024
WO-2025193592-A2 Enhanced nuclear delivery of dna and compositions for use in practicing the same Pending 11-Mar-2024
WO-2025193592-A3 Enhanced nuclear delivery of dna and compositions for use in practicing the same Pending 11-Mar-2024 C12N15/87
To view Seawolf Therapeutics’s complete patent history, request access »

Seawolf Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Seawolf Therapeutics Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alexandria Venture Investments Venture Capital Minority
CRISPR Therapeutics Corporation Minority
Eli Lilly and Company Foundation Limited Partner Minority
MPM BioImpact Venture Capital Minority
Novartis Venture Fund Corporate Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Seawolf Therapeutics FAQs

  • When was Seawolf Therapeutics founded?

    Seawolf Therapeutics was founded in 2021.

  • Where is Seawolf Therapeutics headquartered?

    Seawolf Therapeutics is headquartered in San Diego, CA.

  • What is the size of Seawolf Therapeutics?

    Seawolf Therapeutics has 32 total employees.

  • What industry is Seawolf Therapeutics in?

    Seawolf Therapeutics’s primary industry is Drug Discovery.

  • Is Seawolf Therapeutics a private or public company?

    Seawolf Therapeutics is a Private company.

  • What is the current valuation of Seawolf Therapeutics?

    The current valuation of Seawolf Therapeutics is .

  • What is Seawolf Therapeutics’s current revenue?

    The current revenue for Seawolf Therapeutics is .

  • How much funding has Seawolf Therapeutics raised over time?

    Seawolf Therapeutics has raised $124T.

  • Who are Seawolf Therapeutics’s investors?

    Alexandria Venture Investments, CRISPR Therapeutics, Eli Lilly and Company Foundation, MPM BioImpact, and Novartis Venture Fund are 5 of 8 investors who have invested in Seawolf Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process